Biotechnology in Europe - Market Summary, Competitive Analysis and Forecast to 2025
Biotechnology in Europe - Market Summary, Competitive Analysis and Forecast to 2025
SUMMARY
Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The European biotechnology market had total revenues of $105.8bn in 2020, representing a compound annual growth rate (CAGR) of 10.4% between 2016 and 2020.
- The medical/healthcare segment was the market's most lucrative in 2020, with total revenues of $66.7bn, equivalent to 63% of the market's overall value.
- In the wake of the COVID-19 pandemic, which has stalled the global economy and brought unprecedented levels of uncertainty in many sectors, the future of biotechnology is uncertain. Nonetheless, in the mid%li%to long-term the market as a whole should benefit from rising investment in medicines, as well as government stimulus.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Europe
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Europe
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Europe biotechnology market with five year forecasts
- What was the size of the Europe biotechnology market by value in 2020?
- What will be the size of the Europe biotechnology market in 2025?
- What factors are affecting the strength of competition in the Europe biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Europe's biotechnology market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?
7.5. Are there any threats to leading players?
7.6. Are there any other notable players in the market?
7.7. How might the COVID-19 pandemic affect the competitive landscape?
8 COMPANY PROFILES
8.1. F. Hoffmann-La Roche Ltd
8.2. Novartis AG
8.3. Bayer AG
8.4. AstraZeneca PLC
8.5. BioNTech SE
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?
7.5. Are there any threats to leading players?
7.6. Are there any other notable players in the market?
7.7. How might the COVID-19 pandemic affect the competitive landscape?
8 COMPANY PROFILES
8.1. F. Hoffmann-La Roche Ltd
8.2. Novartis AG
8.3. Bayer AG
8.4. AstraZeneca PLC
8.5. BioNTech SE
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Europe biotechnology industry value: $ billion, 2016-20
Table 2: Europe biotechnology industry category segmentation: $ billion, 2020
Table 3: Europe biotechnology industry geography segmentation: $ billion, 2020
Table 4: Europe biotechnology industry value forecast: $ billion, 2020-25
Table 5: F. Hoffmann-La Roche Ltd: key facts
Table 6: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 7: F. Hoffmann-La Roche Ltd: Key Employees
Table 8: Novartis AG: key facts
Table 9: Novartis AG: Annual Financial Ratios
Table 10: Novartis AG: Key Employees
Table 11: Novartis AG: Key Employees Continued
Table 12: Bayer AG: key facts
Table 13: Bayer AG: Annual Financial Ratios
Table 14: Bayer AG: Key Employees
Table 15: Bayer AG: Key Employees Continued
Table 16: AstraZeneca PLC: key facts
Table 17: AstraZeneca PLC: Annual Financial Ratios
Table 18: AstraZeneca PLC: Key Employees
Table 19: BioNTech SE: key facts
Table 20: BioNTech SE: Annual Financial Ratios
Table 21: BioNTech SE: Key Employees
Table 22: Europe size of population (million), 2016-20
Table 23: Europe gdp (constant 2005 prices, $ billion), 2016-20
Table 24: Europe gdp (current prices, $ billion), 2016-20
Table 25: Europe inflation, 2016-20
Table 26: Europe consumer price index (absolute), 2016-20
Table 27: Europe exchange rate, 2016-20
Table 1: Europe biotechnology industry value: $ billion, 2016-20
Table 2: Europe biotechnology industry category segmentation: $ billion, 2020
Table 3: Europe biotechnology industry geography segmentation: $ billion, 2020
Table 4: Europe biotechnology industry value forecast: $ billion, 2020-25
Table 5: F. Hoffmann-La Roche Ltd: key facts
Table 6: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 7: F. Hoffmann-La Roche Ltd: Key Employees
Table 8: Novartis AG: key facts
Table 9: Novartis AG: Annual Financial Ratios
Table 10: Novartis AG: Key Employees
Table 11: Novartis AG: Key Employees Continued
Table 12: Bayer AG: key facts
Table 13: Bayer AG: Annual Financial Ratios
Table 14: Bayer AG: Key Employees
Table 15: Bayer AG: Key Employees Continued
Table 16: AstraZeneca PLC: key facts
Table 17: AstraZeneca PLC: Annual Financial Ratios
Table 18: AstraZeneca PLC: Key Employees
Table 19: BioNTech SE: key facts
Table 20: BioNTech SE: Annual Financial Ratios
Table 21: BioNTech SE: Key Employees
Table 22: Europe size of population (million), 2016-20
Table 23: Europe gdp (constant 2005 prices, $ billion), 2016-20
Table 24: Europe gdp (current prices, $ billion), 2016-20
Table 25: Europe inflation, 2016-20
Table 26: Europe consumer price index (absolute), 2016-20
Table 27: Europe exchange rate, 2016-20
LIST OF FIGURES
Figure 1: Europe biotechnology industry value: $ billion, 2016-20
Figure 2: Europe biotechnology industry category segmentation: % share, by value, 2020
Figure 3: Europe biotechnology industry geography segmentation: % share, by value, 2020
Figure 4: Europe biotechnology industry value forecast: $ billion, 2020-25
Figure 5: Forces driving competition in the biotechnology industry in Europe, 2020
Figure 6: Drivers of buyer power in the biotechnology industry in Europe, 2020
Figure 7: Drivers of supplier power in the biotechnology industry in Europe, 2020
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Europe, 2020
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Europe, 2020
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Europe, 2020
Figure 1: Europe biotechnology industry value: $ billion, 2016-20
Figure 2: Europe biotechnology industry category segmentation: % share, by value, 2020
Figure 3: Europe biotechnology industry geography segmentation: % share, by value, 2020
Figure 4: Europe biotechnology industry value forecast: $ billion, 2020-25
Figure 5: Forces driving competition in the biotechnology industry in Europe, 2020
Figure 6: Drivers of buyer power in the biotechnology industry in Europe, 2020
Figure 7: Drivers of supplier power in the biotechnology industry in Europe, 2020
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Europe, 2020
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Europe, 2020
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Europe, 2020
